Praxis Precision Medicines to Participate in Five Upcoming Investor Conferences

Rhea-AI Summary

Praxis Precision Medicines (NASDAQ: PRAX), a clinical-stage biopharmaceutical company focused on developing CNS disorder therapies, has announced its participation in five major investor conferences in March 2025:

• 45th Annual TD Cowen Health Care Conference in Boston (March 5, 9:10 AM EDT)
• Leerink Partners Global Healthcare Conference in Miami (March 10, 3:40 PM EDT)
• Jefferies Biotech on the Bay Summit in Miami (March 11)
• Barclays 27th Annual Global Healthcare Conference in Miami (March 12, 2:30 PM EDT)
• UBS Virtual CNS Day (March 17, 9:30 AM EDT)

The company will present corporate overviews, participate in fireside chats, and offer one-on-one investor meetings. Live webcasts will be available for most events, with 90-day replay access through the company's website.

BOSTON, March 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that it will be participating in five upcoming investor conferences:

• Praxis management will be presenting a corporate overview at the 45^th Annual TD Cowen Health Care Conference, taking place at the Boston Marriott Copley Place in Boston on Wednesday, March 5, 2025 at 9:10a.m. EDT. A live webcast of the event will be available through this link.
• Praxis management will also be participating in a fireside chat at the Leerink Partners Global Healthcare Conference, taking place at the W South Beach Hotel in Miami on Monday, March 10, 2025 at 3:40p.m. EDT. A live webcast of the event will be available through this link.
• Praxis management will also be participating in one-on-one investor meetings at the Jefferies Biotech on the Bay Summit, taking place at the Ritz Carlton South Beach Hotel in Miami on Tuesday, March 11, 2025.
• Praxis management will also be participating in a fireside chat at the Barclays 27^th Annual Global Healthcare Conference, taking place at the Loews Miami South Beach Hotel in Miami on Wednesday, March 12, 2025 at 2:30p.m. EDT. A live webcast of the event will be available through this link.
• Praxis management will also be participating in a fireside chat at the UBS Virtual CNS Day, taking place on March 17, 2025 at 9:30a.m. EDT. A live webcast of the event will be available through this link.
  

The Company will be available for one-on-one meetings during all events. Interested investors should contact their respective representatives to request meetings.

Replays of the webcasted events will also be available through the “Events & Presentations” page under the “Investors + Media” section of the company’s website for 90 days.

About Praxis  
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating insights from genetic epilepsies into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. Praxis is applying genetic insights to the discovery and development of therapies for rare and more prevalent neurological disorders through our proprietary small molecule platform, Cerebrum™, and antisense oligonucleotide (ASO) platform, Solidus™, using our understanding of shared biological targets and circuits in the brain. Praxis has established a diversified, multimodal CNS portfolio including multiple programs across movement disorders and epilepsy, with four clinical-stage product candidates. For more information, please visit www.praxismedicines.com and follow us on Facebook, LinkedIn and Twitter/X. 

FAQ

What investor conferences will Praxis Precision Medicines (PRAX) attend in March 2025?

PRAX will attend five conferences: TD Cowen Health Care Conference (March 5), Leerink Partners Global Healthcare Conference (March 10), Jefferies Biotech Summit (March 11), Barclays Global Healthcare Conference (March 12), and UBS Virtual CNS Day (March 17).

How can investors access Praxis (PRAX) conference presentations in March 2025?

Live webcasts will be available for most events through provided links, with 90-day replay access through the 'Events & Presentations' page on PRAX's website.

Where will Praxis Precision Medicines (PRAX) host one-on-one investor meetings in March 2025?

PRAX will be available for one-on-one meetings at all five events. Interested investors should contact their representatives to schedule meetings.

What is the focus of Praxis Precision Medicines' (PRAX) therapeutic development?

PRAX focuses on developing therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance.